Diabetic Retinopathy Market to Witness $2,490 Million Value, Globally by 2022: AMR Research Report
"There have been remarkable advancements in the diagnosis and treatment of diabetic retinopathy in the recent years. Rapid adoption of intravitreal pharmacological agents such as anti-VEGF drugs, and corticosteroids have led to improvement of vision in DR patients."
View full press release